Support, Monitoring, and Reminder Technology for Mild Dementia (SMART4MD) for People With Mild Cognitive Impairment and Their Informal Caregivers: Cost-Effectiveness Analysis
(2026) In JMIR Human Factors 13. p.1-17- Abstract
- Background:
Support, Monitoring, and Reminder Technology for Mild Dementia (SMART4MD), a customized tablet app, was developed to improve or maintain the quality of life of people with mild cognitive impairment (MCI) and their informal caregivers.
Objective:
This study conducts an 18-month economic evaluation of the SMART4MD app, in addition to standard care, compared with standard care alone in Sweden and Spain, from a health care provider perspective.
Methods:
In a pragmatic randomized controlled trial, people with MCI and their informal caregivers were randomized to the intervention and control groups. Health care costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs)... (More) - Background:
Support, Monitoring, and Reminder Technology for Mild Dementia (SMART4MD), a customized tablet app, was developed to improve or maintain the quality of life of people with mild cognitive impairment (MCI) and their informal caregivers.
Objective:
This study conducts an 18-month economic evaluation of the SMART4MD app, in addition to standard care, compared with standard care alone in Sweden and Spain, from a health care provider perspective.
Methods:
In a pragmatic randomized controlled trial, people with MCI and their informal caregivers were randomized to the intervention and control groups. Health care costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs) were measured in 345 Swedish people with MCI and their informal caregivers, and in 347 Spanish people with MCI.
Results:
The analysis showed higher incremental costs and lower QALYs for Swedish people with MCI than for controls, whereas higher incremental costs and higher QALYs were observed for Spanish people with MCI. The intervention was not found to be cost-effective for Swedish informal caregivers, with an ICER of €78,000/QALY (€1=US $1.16).
Conclusions:
The differing findings regarding cost-effectiveness for people with MCI in Sweden and Spain highlight the need for further research with extended follow-up, ideally involving a larger sample size and conducted across different national contexts. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/05fb0bd8-2b4b-464b-90c5-405e89bba58c
- author
- organization
- publishing date
- 2026-05-21
- type
- Contribution to journal
- publication status
- published
- subject
- in
- JMIR Human Factors
- volume
- 13
- article number
- e77808
- pages
- 1 - 17
- publisher
- JMIR Publications Inc.
- external identifiers
-
- pmid:42172614
- ISSN
- 2292-9495
- DOI
- 10.2196/77808
- language
- English
- LU publication?
- yes
- id
- 05fb0bd8-2b4b-464b-90c5-405e89bba58c
- date added to LUP
- 2026-05-22 21:15:16
- date last changed
- 2026-05-25 09:08:13
@article{05fb0bd8-2b4b-464b-90c5-405e89bba58c,
abstract = {{Background:<br/>Support, Monitoring, and Reminder Technology for Mild Dementia (SMART4MD), a customized tablet app, was developed to improve or maintain the quality of life of people with mild cognitive impairment (MCI) and their informal caregivers.<br/><br/>Objective:<br/>This study conducts an 18-month economic evaluation of the SMART4MD app, in addition to standard care, compared with standard care alone in Sweden and Spain, from a health care provider perspective.<br/><br/>Methods:<br/>In a pragmatic randomized controlled trial, people with MCI and their informal caregivers were randomized to the intervention and control groups. Health care costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs) were measured in 345 Swedish people with MCI and their informal caregivers, and in 347 Spanish people with MCI.<br/><br/>Results:<br/>The analysis showed higher incremental costs and lower QALYs for Swedish people with MCI than for controls, whereas higher incremental costs and higher QALYs were observed for Spanish people with MCI. The intervention was not found to be cost-effective for Swedish informal caregivers, with an ICER of €78,000/QALY (€1=US $1.16).<br/><br/>Conclusions:<br/>The differing findings regarding cost-effectiveness for people with MCI in Sweden and Spain highlight the need for further research with extended follow-up, ideally involving a larger sample size and conducted across different national contexts.}},
author = {{Ghani, Zartashia and Jarl, Johan and Anderberg, Peter and Sanmartin Berglund, Johan and Quintana Aparicio, Maria and Barnestein-Fonseca, Pilar and Cellek, Selim and Mayoral-Cleries, Fermín and Garolera, Maite and Guerrero-Pertiñez, Gloria and Hayden, Karen and Moore, Carmel Maria and Zhang, Jufen and Trepel, Dominic and Saha, Sanjib}},
issn = {{2292-9495}},
language = {{eng}},
month = {{05}},
pages = {{1--17}},
publisher = {{JMIR Publications Inc.}},
series = {{JMIR Human Factors}},
title = {{Support, Monitoring, and Reminder Technology for Mild Dementia (SMART4MD) for People With Mild Cognitive Impairment and Their Informal Caregivers: Cost-Effectiveness Analysis}},
url = {{http://dx.doi.org/10.2196/77808}},
doi = {{10.2196/77808}},
volume = {{13}},
year = {{2026}},
}
